Animal Model Market to Grow with a CAGR of 7.64% through 2028
Rise in demand for personalized medicine are expected
to drive the Global Animal Model Market growth in the forecast period,
2024-2028.
According to TechSci Research report, “Animal Model
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2028”, the Global Animal Model Market stood at USD 1.67
billion in 2022 and is anticipated to grow with a CAGR of 7.64% in the forecast
period, 2024-2028 The global burden of chronic diseases, such as cancer,
diabetes, cardiovascular diseases, and neurological disorders, continues to
grow. As a result, there is a pressing need for the development of novel
pharmaceuticals and treatments. Animal models are instrumental in preclinical
testing, helping researchers evaluate drug safety, efficacy, and mechanisms of
action. This significantly reduces the risks associated with human clinical
trials. The demand for more effective therapies to combat these chronic
conditions is a major driver behind the growth of the animal model market.
One of the most significant drivers of the animal
model market is the continuous evolution of genetic engineering techniques.
Researchers can now create genetically modified animals that closely mimic
human physiological and pathological conditions. These genetically engineered
models have paved the way for innovative research in genetic disorders and
personalized medicine. By introducing specific genes or mutations into animals,
scientists can better understand the genetic basis of diseases and test potential
therapies with a high degree of precision. The era of personalized medicine is
upon us, where treatments are tailored to an individual's unique genetic makeup
and disease profile. Animal models are a crucial component of this paradigm
shift, enabling researchers to study how individual genetic variations impact
drug responses and disease outcomes. This trend is driving demand for animal
models that can accurately replicate human genetic diversity, which, in turn,
is boosting the market for genetically diverse animal models.
The pharmaceutical and biotechnology industries are
expanding rapidly, with a focus on developing innovative drugs and therapies.
Animal models remain an essential tool for drug discovery and preclinical
testing. By using animal models to test the safety and efficacy of potential
drug candidates, pharmaceutical companies can streamline their drug development
pipelines and reduce the time and costs associated with bringing new
medications to market. This efficiency is a major driver behind the continued growth
of the animal model market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Animal Model Market”
The Global Animal Model Market is segmented into Animal
Type, Application, Distribution Channel, Regional Distribution,
And Company.
Based
on the Animal Type, Mice emerged as the dominant segment in the global market
for Global Animal Model Market in 2022. There is a wide variety of established
and well-characterized mouse strains, each with its own unique genetic and
physiological features. This diversity allows researchers to select strains
that closely match the characteristics of the diseases they wish to study. Mice
are small and relatively easy to house and care for in laboratory settings.
Their size makes them practical for researchers who need to maintain large
populations of animals, and their small footprint reduces the space and
resource requirements compared to larger animals. Mice are more cost-effective
to maintain and breed than larger animals like rabbits or non-human primates.
The lower associated costs make mice a more accessible and affordable option
for a wide range of research institutions, including smaller universities and
research laboratories. Mice
have a long history of use in scientific research, resulting in an extensive
body of knowledge, established protocols, and a large number of commercially
available tools and resources, such as antibodies, cell lines, and transgenic
mice. This widespread use facilitates collaboration and data sharing in the
scientific community.
Based on the Application,
Cancer emerged as the dominant segment in the global market for Global Animal
Model Market in 2022. animal models play a critical role in
cancer drug development. They are used to assess the safety, efficacy, and
potential side effects of new cancer therapies and drugs. Researchers rely on
animal models to test novel treatments, evaluate their mechanisms of action,
and determine optimal dosages. This application is particularly crucial as the
development of effective cancer therapies remains a top priority in the medical
field. Cancer research often involves the study of genetic mutations and
molecular pathways that drive tumor growth. Genetically engineered animal
models, such as mice with specific cancer-related mutations, are invaluable
tools for understanding the genetic underpinnings of cancer and testing
targeted therapies. These models enable researchers to closely mimic the
genetic conditions found in human cancer patients.
Based on the Distribution Channel,
Pharmaceutical & Biotechnology Companies emerged as the dominant segment in
the global market for Global Animal Model Market in 2022. Pharmaceutical
and biotechnology companies are at the forefront of drug discovery and
development. They conduct extensive in-house research to bring new medications
and therapies to market. These organizations require animal models for
preclinical testing, safety evaluations, and efficacy studies to advance their
drug candidates. Pharmaceutical and biotechnology companies engage in a wide
range of research activities, from oncology to neuroscience and cardiovascular
disease. Their diverse research needs necessitate access to a variety of animal
models that can closely mimic the specific diseases and conditions they are
targeting.
North America emerged as the dominant
player in the global Animal Model Market in 2022, holding the largest market
share. North America, particularly the United States, is home to a thriving and
well-established biomedical and pharmaceutical industry. The presence of
numerous pharmaceutical and biotechnology companies, academic research
institutions, and medical centers drives the demand for animal models. These
organizations heavily rely on animal models for preclinical research and drug
development, contributing significantly to the market's growth. The region has
been at the forefront of developments in genetic engineering techniques, such
as CRISPR-Cas9 technology. These techniques enable the creation of genetically
modified animal models that closely mimic human genetic conditions and
diseases. North American researchers and organizations have been quick to adopt
these technologies, driving the demand for genetically engineered animal models.
Major companies operating in Global Animal Model Market
are:
- Charles River Laboratories
- The Jackson Laboratory
- genOway
- Taconic Biosciences, Inc.
- Janvier Labs
- Harbour BioMed
- Crown Bioscience
- Inotiv
- BIOCYTOGEN
- BioSpherix, Ltd
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Global Animal
Model Market is poised for significant growth in the coming years. The
ever-increasing prevalence of chronic diseases, along with the pressing need
for personalized medicine, is driving extensive research and development
efforts that heavily rely on animal models. Advancements in genetic engineering
techniques and the development of more sophisticated animal models, including
humanized models, are expanding the utility and relevance of these models in
translational research. Additionally, the ethical concerns surrounding animal
welfare have prompted a push for more responsible and transparent research
practices, which are expected to enhance the credibility and utility of animal
models.” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Animal Model Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Animal Type
(Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others), By Application (Cancer,
Immunological Disease, Infectious Disease, Others), By Distribution Channel
(Pharmaceutical & Biotechnology Companies, Academic Research Institute,
Contract Research Organization) Region and Competition”, has evaluated
the future growth potential of Global Animal Model Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Animal Model Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com